相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments
P. Zarzosa et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2017)
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice (vol 29, pg 574, 2016)
Elizabeth C. Townsend et al.
CANCER CELL (2016)
A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds
Alejandra Bruna et al.
CELL (2016)
The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities
Elizabeth Stewart et al.
DEVELOPMENTAL BIOLOGY (2016)
Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs
Marc Hafner et al.
NATURE METHODS (2016)
Preclinical Models Provide Scientific Justification and Translational Relevance for Moving Novel Therapeutics into Clinical Trials for Pediatric Cancer
David M. Langenau et al.
CANCER RESEARCH (2015)
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Marc van de Wetering et al.
CELL (2015)
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
Sylvia F. Boj et al.
CELL (2015)
Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors
Khanh Do et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
Hui Gao et al.
NATURE MEDICINE (2015)
Pediatric solid tumor genomics and developmental pliancy
X. Chen et al.
ONCOGENE (2015)
Genomic landscape of paediatric adrenocortical tumours
Emilia M. Pinto et al.
NATURE COMMUNICATIONS (2015)
Declining Childhood and Adolescent Cancer Mortality
Malcolm A. Smith et al.
CANCER (2014)
Functional Heterogeneity of Genetically Defined Subclones in Acute Myeloid Leukemia
Jeffery M. Klco et al.
CANCER CELL (2014)
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Dong Gao et al.
CELL (2014)
Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 Mutations
Franck Tirode et al.
CANCER DISCOVERY (2014)
Targeting the DNA Repair Pathway in Ewing Sarcoma
Elizabeth Stewart et al.
CELL REPORTS (2014)
Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
Xiang Chen et al.
CELL REPORTS (2014)
Targeting Oxidative Stress in Embryonal Rhabdomyosarcoma
Xiang Chen et al.
CANCER CELL (2013)
Panobinostat Enhances Cytarabine and Daunorubicin Sensitivities in AML Cells through Suppressing the Expression of BRCA1, CHK1, and Rad51
Chengzhi Xie et al.
PLOS ONE (2013)
ChromHMM: automating chromatin-state discovery and characterization
Jason Ernst et al.
NATURE METHODS (2012)
Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma
Donna E. Reece et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
The analysis of 2 x 2 contingency tables-Yet again
John T. E. Richardson
STATISTICS IN MEDICINE (2011)
Evaluation of homogenization techniques for the preparation of mouse tissue samples to support drug discovery
Xiaorong Liang et al.
BIOANALYSIS (2011)
In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma
Enrique M. Ocio et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges
Peter Atadja
CANCER LETTERS (2009)
Comments on 'Chi-squared and Fisher-Irwin tests of two-by-two tables with small sample recommendations'
Antonio Martin Andres
STATISTICS IN MEDICINE (2008)
Chi-squared and Fisher-Irwin tests of two-by-two tables with small sample recommendations
Ian Campbell
STATISTICS IN MEDICINE (2007)
分享论文
